Myasthenia gravis and pregnancy.
Treatment considerations for women who have MG and are of childbearing age are complicated. When possible, before pregnancy, establishing a plan for therapy is ideal, recognizing the potential concerns for the patient and the fetus. Decisions about treatment during pregnancy must balance the potential complications for the fetus, the patient, and even the integrity of the pregnancy. Most women who have MG are able to complete pregnancy successfully and deliver a healthy baby; however, there always is some risk that NMG may occur. Pregnant patients who have MG are served best at centers capable of providing coordinated expert care from neurologic, obstetric, and pediatric providers.
Ciafaloni
Emma
E
Neuromuscular Section, Department of Neurology, University of Rochester, School of Dentistry and Medicine, Rochester, NY, USA.
Massey
Janice M
JM
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000175:diagnosis* / Q000628:therapy; D010956:Plasmapheresis; D011247:Pregnancy; D011248:Pregnancy Complications
D000893:Anti-Inflammatory Agents; D002800:Cholinesterase Inhibitors